Specifically, tumor-associated endothelial cells can produce molecular factors such as PD-L1 [29], Fas ligand (FasL) [30, 31], or vascular endothelial growth factor (VEGF) [32] that critically modulate immune responses in the tumor environment. This evidence concerns the gene CD274 and neoplasm.